Guardant Health Files Q1 2024 10-Q
Ticker: GH · Form: 10-Q · Filed: 2024-05-09T00:00:00.000Z
Sentiment: neutral
Topics: 10-Q, financials, healthcare
TL;DR
Guardant Health's Q1 2024 10-Q is in. Check financials.
AI Summary
Guardant Health, Inc. filed its 10-Q for the period ending March 31, 2024. The filing details financial performance and operational updates for the first quarter of 2024. Key financial figures and business developments are presented within this report.
Why It Matters
This filing provides investors and stakeholders with the latest financial health and strategic direction of Guardant Health, a key player in the liquid biopsy market.
Risk Assessment
Risk Level: medium — As a publicly traded company in the biotech sector, Guardant Health faces inherent risks related to market competition, regulatory approvals, and financial performance.
Key Players & Entities
- Guardant Health, Inc. (company) — Filer of the 10-Q
- 20240331 (date) — End of the reporting period
- 20240509 (date) — Filing date
FAQ
What is the reporting period for this 10-Q filing?
The reporting period for this 10-Q filing is the quarter ended March 31, 2024.
When was this 10-Q filed with the SEC?
This 10-Q was filed on May 9, 2024.
What is the company's primary business as indicated by the SIC code?
The company's SIC code is 8071, which corresponds to SERVICES-MEDICAL LABORATORIES.
Where is Guardant Health, Inc. headquartered?
Guardant Health, Inc. is headquartered at 3100 Hanover Street, Palo Alto, CA 94304.
What is the fiscal year end for Guardant Health, Inc.?
The fiscal year end for Guardant Health, Inc. is December 31.
From the Filing
0001576280-24-000109.txt : 20240509 0001576280-24-000109.hdr.sgml : 20240509 20240509165952 ACCESSION NUMBER: 0001576280-24-000109 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 79 CONFORMED PERIOD OF REPORT: 20240331 FILED AS OF DATE: 20240509 DATE AS OF CHANGE: 20240509 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Guardant Health, Inc. CENTRAL INDEX KEY: 0001576280 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 454139254 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-38683 FILM NUMBER: 24931678 BUSINESS ADDRESS: STREET 1: 3100 HANOVER STREET CITY: PALO ALTO STATE: CA ZIP: 94304 BUSINESS PHONE: 855-698-8887 MAIL ADDRESS: STREET 1: 3100 HANOVER STREET CITY: PALO ALTO STATE: CA ZIP: 94304 10-Q 1 gh-20240331.htm 10-Q gh-20240331 false 2024 Q1 0001576280 12-31 0.0071523 xbrli:shares iso4217:USD iso4217:USD xbrli:shares xbrli:pure gh:segment gh:trading_day gh:patent gh:tranche 0001576280 2024-01-01 2024-03-31 0001576280 2024-05-03 0001576280 2024-03-31 0001576280 2023-12-31 0001576280 2023-01-01 2023-03-31 0001576280 us-gaap:CommonStockMember 2023-12-31 0001576280 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001576280 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 0001576280 us-gaap:RetainedEarningsMember 2023-12-31 0001576280 us-gaap:CommonStockMember 2024-01-01 2024-03-31 0001576280 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-03-31 0001576280 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-01-01 2024-03-31 0001576280 us-gaap:RetainedEarningsMember 2024-01-01 2024-03-31 0001576280 us-gaap:CommonStockMember 2024-03-31 0001576280 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0001576280 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-03-31 0001576280 us-gaap:RetainedEarningsMember 2024-03-31 0001576280 us-gaap:CommonStockMember 2022-12-31 0001576280 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001576280 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0001576280 us-gaap:RetainedEarningsMember 2022-12-31 0001576280 2022-12-31 0001576280 us-gaap:CommonStockMember 2023-01-01 2023-03-31 0001576280 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0001576280 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-03-31 0001576280 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0001576280 us-gaap:CommonStockMember 2023-03-31 0001576280 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001576280 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-03-31 0001576280 us-gaap:RetainedEarningsMember 2023-03-31 0001576280 2023-03-31 0001576280 2023-01-01 2023-12-31 0001576280 2022-01-01 2022-12-31 0001576280 2023-06-01 2023-06-30 0001576280 us-gaap:CustomerConcentrationRiskMember gh:CustomerAMember us-gaap:AccountsReceivableMember 2024-01-01 2024-03-31 0001576280 us-gaap:CustomerConcentrationRiskMember gh:CustomerAMember us-gaap:AccountsReceivableMember 2023-01-01 2023-12-31 0001576280 gh:CustomerBMember us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember 2024-01-01 2024-03-31 0001576280 gh:CustomerBMember us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember 2023-01-01 2023-03-31 0001576280 gh:CustomerBMember us-gaap:CustomerConcentrationRiskMember us-gaap:AccountsReceivableMember 2024-01-01 2024-03-31 0001576280 gh:CustomerBMember us-gaap:CustomerConcentrationRiskMember us-gaap:AccountsReceivableMember 2023-01-01 2023-12-31 0001576280 us-gaap:CustomerConcentrationRiskMember gh:CustomerCMember us-gaap:AccountsReceivableMember 2023-01-01 2023-12-31 0001576280 srt:MinimumMember 2024-03-31 0001576280 srt:MaximumMember 2024-03-31 0001576280 srt:MinimumMember 2024-04-01 2024-03-31 0001576280 srt:MaximumMember 2024-04-01 2024-03-31 0001576280 us-gaap:MachineryAndEquipmentMember 2024-03-31 0001576280 us-gaap:MachineryAndEquipmentMember 2023-12-31 000157628